These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23124289)

  • 1. Pathogenesis of hepatitis B virus infection and potential for new therapies.
    Peppa D; Maini MK
    Br J Hosp Med (Lond); 2012 Oct; 73(10):581-4. PubMed ID: 23124289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response?
    Koh S; Bertoletti A
    Med Microbiol Immunol; 2015 Feb; 204(1):87-94. PubMed ID: 25511870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic hepatitis B: immune pathogenesis and emerging immunotherapeutics.
    Chang KM; Liu M
    Curr Opin Pharmacol; 2016 Oct; 30():93-105. PubMed ID: 27570126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immunity and HBV persistence.
    Chiale C; Marchese AM; Robek MD
    Curr Opin Virol; 2021 Aug; 49():13-20. PubMed ID: 33992859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection.
    Meng Z; Chen Y; Lu M
    Front Immunol; 2019; 10():3127. PubMed ID: 32117201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunology of hepatitis B.
    Vierling JM
    Clin Liver Dis; 2007 Nov; 11(4):727-59, vii-viii. PubMed ID: 17981227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune therapeutic strategies in chronic hepatitis B virus infection: virus or inflammation control?
    Bertoletti A; Gehring AJ
    PLoS Pathog; 2013; 9(12):e1003784. PubMed ID: 24367255
    [No Abstract]   [Full Text] [Related]  

  • 8. Toward Curative Immunomodulation Strategies for Chronic Hepatitis B Virus Infection.
    Zhu W; Liu H; Zhang X
    ACS Infect Dis; 2019 May; 5(5):703-712. PubMed ID: 30907080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection.
    Bertoletti A; Ferrari C
    Gut; 2012 Dec; 61(12):1754-64. PubMed ID: 22157327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapeutic interventions in chronic hepatitis B virus infection: a review.
    Wang L; Zou ZQ; Liu CX; Liu XZ
    J Immunol Methods; 2014 May; 407():1-8. PubMed ID: 24747918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in therapeutics for chronic hepatitis B.
    Yang N; Bertoletti A
    Hepatol Int; 2016 Mar; 10(2):277-85. PubMed ID: 26363922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Innate and Adaptive Immune Responses to Cure Chronic HBV Infection.
    Gehring AJ; Protzer U
    Gastroenterology; 2019 Jan; 156(2):325-337. PubMed ID: 30367834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between hepatitis B virus and the innate immune responses: implications for new therapeutic strategies.
    Chen J; Yuan Z
    Virol Sin; 2014 Feb; 29(1):17-24. PubMed ID: 24452540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.
    Ma Z; Zhang E; Yang D; Lu M
    Cell Mol Immunol; 2015 May; 12(3):273-82. PubMed ID: 25418467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate and adaptive immune responses in hepatitis B virus infection.
    Das A; Maini MK
    Dig Dis; 2010; 28(1):126-32. PubMed ID: 20460900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive immunity in HBV infection.
    Bertoletti A; Ferrari C
    J Hepatol; 2016 Apr; 64(1 Suppl):S71-S83. PubMed ID: 27084039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activating adaptive immunity by bispecific, T-cell engager antibodies bridging infected and immune-effector cells is a promising novel therapy for chronic hepatitis B.
    Xie Z; Protzer U
    Antiviral Res; 2024 Sep; 229():105972. PubMed ID: 39084340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy for Chronic Hepatitis B Virus Infection.
    Bertoletti A; Le Bert N
    Gut Liver; 2018 Sep; 12(5):497-507. PubMed ID: 29316747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of hepatitis B virus-induced systemic immune tolerance by intrinsic innate immune stimulation.
    Han Q; Lan P; Zhang J; Zhang C; Tian Z
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():132-7. PubMed ID: 23855309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B immunopathogenesis and immunotherapy.
    Golsaz-Shirazi F; Shokri F
    Immunotherapy; 2016; 8(4):461-77. PubMed ID: 26973127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.